Reports

Industry Research Reports

Home > Reports > Service & Software > Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-09

Pages: 105 Pages

Report ld: 6064703

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Cancer Diagnostics Service Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

9.9%

marketSize

Market Size,2032

USD 294,080

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 167,280 million
Market Forecast in 2032(Value)
US$ 294,080 million
CAGR
9.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cancer Diagnostics Service market size was US$ 153640 million in 2025 and is forecast to reach a readjusted size of US$ 294080 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.

Cancer diagnostic services refer to medical technology services that utilize imaging examinations (such as CT, MRI, PET-CT) and in vitro diagnostics (including tumor marker detection, liquid biopsy, gene sequencing, pathological sections, and molecular subtyping) to provide early cancer screening, diagnosis, subtyping, staging, and medication guidance for suspected or high-risk individuals. This encompasses the entire process from sample collection and laboratory analysis to clinical interpretation. The upstream of the industry chain includes suppliers of high-throughput sequencers (Illumina, Thermo Fisher), antibody reagents, fluorescent probes, pathology equipment, AI-assisted diagnostic algorithms, and bioinformatics databases. The midstream consists of diagnostic service providers, who must possess CAP/CLIA or China National Institutes for Clinical Laboratories certification, NGS platforms, bioinformatics analysis capabilities, and compliant data management systems. The downstream primarily targets hospitals, health checkup centers, pharmaceutical companies (with companion diagnostics collaborations), and individual consumers. Due to its technology-intensive nature, high licensing barriers, and the inclusion of some services in medical insurance, the industry's overall gross profit margin is between 50% and 75%, with routine pathology and immunohistochemistry gross profit margins around 40%–60%, while NGS-based multi-cancer early screening or MRD monitoring services can achieve gross profit margins exceeding 70%.

The Cancer Diagnostics Service market is expanding rapidly due to the rising global cancer incidence, aging populations, and increasing demand for early detection. Advances in molecular diagnostics, next-generation sequencing, and liquid biopsy technologies are transforming traditional cancer testing into more precise and less invasive approaches. Governments are strengthening cancer screening programs, while precision medicine is driving higher demand for companion diagnostics. Additionally, AI-powered imaging analysis and digital pathology platforms are improving diagnostic efficiency and accuracy. In the future, integrated multi-omics diagnostics and personalized cancer screening solutions will further drive sustained growth of the global cancer diagnostics service market.

The global Cancer Diagnostics Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • UCSF Health
  • Abbott
  • QIAGEN
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Applied DNA Sciences
  • TherapySelect
  • Caris Life Sciences
  • Foresight Diagnostics
  • Smartpraxis
  • Amadix
  • Check4Cancer
  • Hologic
  • RGCC
  • ICON

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Others

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others

Segment by Category

  • Imaging-based Cancer Diagnostics
  • Pathology-based Cancer Diagnostics
  • Molecular Cancer Diagnostics
  • Biomarker-based Cancer Diagnostics

Segment by Division

  • Genetic Testing
  • Liquid Biopsy
  • Tissue Biopsy
  • Immunohistochemistry (IHC)

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cancer Diagnostics Service value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Breast Cancer

1.2.3 Blood Cancer

1.2.4 Lung Cancer

1.2.5 Colorectal Cancer

1.2.6 Ovarian Cancer

1.2.7 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Cancer Diagnostics Service Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Cancer Diagnostics Service Market Share by Revenue, by Region (2021-2026)

2.4 Global Cancer Diagnostics Service Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Cancer Diagnostics Service Market Size and Prospective (2021-2032)

2.5.2 Europe Cancer Diagnostics Service Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Cancer Diagnostics Service Market Size and Prospective (2021-2032)

2.5.4 Latin America Cancer Diagnostics Service Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Cancer Diagnostics Service Market Size and Prospective (2021-2032)

muLu

3 Breakdown Data by Type

3.1 Global Cancer Diagnostics Service Historical Market Size by Type (2021-2026)

3.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Cancer Diagnostics Service

muLu

4 Breakdown Data by Application

4.1 Global Cancer Diagnostics Service Historical Market Size by Application (2021-2026)

4.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Cancer Diagnostics Service Applications

muLu

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2021-2026)

5.1.2 Global Cancer Diagnostics Service Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Cancer Diagnostics Service Revenue

5.4 Global Cancer Diagnostics Service Market Concentration Analysis

5.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2025

5.5 Global Key Players of Cancer Diagnostics Service Head Offices and Areas Served

5.6 Global Key Players of Cancer Diagnostics Service, Product and Application

5.7 Global Key Players of Cancer Diagnostics Service, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Cancer Diagnostics Service Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Cancer Diagnostics Service Market Size by Type (2021-2026)

6.1.2.2 North America Cancer Diagnostics Service Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Cancer Diagnostics Service Market Size by Application (2021-2026)

6.1.3.2 North America Cancer Diagnostics Service Market Share by Application (2021-2026)

6.1.4 North America Cancer Diagnostics Service Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Cancer Diagnostics Service Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Cancer Diagnostics Service Market Size by Type (2021-2026)

6.2.2.2 Europe Cancer Diagnostics Service Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Cancer Diagnostics Service Market Size by Application (2021-2026)

6.2.3.2 Europe Cancer Diagnostics Service Market Share by Application (2021-2026)

6.2.4 Europe Cancer Diagnostics Service Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Cancer Diagnostics Service Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Cancer Diagnostics Service Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Cancer Diagnostics Service Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Cancer Diagnostics Service Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Cancer Diagnostics Service Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Cancer Diagnostics Service Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Cancer Diagnostics Service Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Cancer Diagnostics Service Market Size by Type (2021-2026)

6.4.2.2 Latin America Cancer Diagnostics Service Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Cancer Diagnostics Service Market Size by Application (2021-2026)

6.4.3.2 Latin America Cancer Diagnostics Service Market Share by Application (2021-2026)

6.4.4 Latin America Cancer Diagnostics Service Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Cancer Diagnostics Service Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Cancer Diagnostics Service Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Cancer Diagnostics Service Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Cancer Diagnostics Service Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Cancer Diagnostics Service Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Cancer Diagnostics Service Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

muLu

7 Key Player Profiles

7.1 Illumina

7.1.1 Illumina Company Details

7.1.2 Illumina Business Overview

7.1.3 Illumina Cancer Diagnostics Service Introduction

7.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2021-2026)

7.1.5 Illumina Recent Development

7.2 BGI Genomics Co.,Ltd.

7.2.1 BGI Genomics Co.,Ltd. Company Details

7.2.2 BGI Genomics Co.,Ltd. Business Overview

7.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction

7.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2021-2026)

7.2.5 BGI Genomics Co.,Ltd. Recent Development

7.3 Agilent Technologies

7.3.1 Agilent Technologies Company Details

7.3.2 Agilent Technologies Business Overview

7.3.3 Agilent Technologies Cancer Diagnostics Service Introduction

7.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2021-2026)

7.3.5 Agilent Technologies Recent Development

7.4 Macrogen

7.4.1 Macrogen Company Details

7.4.2 Macrogen Business Overview

7.4.3 Macrogen Cancer Diagnostics Service Introduction

7.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2021-2026)

7.4.5 Macrogen Recent Development

7.5 UCSF Health

7.5.1 UCSF Health Company Details

7.5.2 UCSF Health Business Overview

7.5.3 UCSF Health Cancer Diagnostics Service Introduction

7.5.4 UCSF Health Revenue in Cancer Diagnostics Service Business (2021-2026)

7.5.5 UCSF Health Recent Development

7.6 Abbott

7.6.1 Abbott Company Details

7.6.2 Abbott Business Overview

7.6.3 Abbott Cancer Diagnostics Service Introduction

7.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2021-2026)

7.6.5 Abbott Recent Development

7.7 QIAGEN

7.7.1 QIAGEN Company Details

7.7.2 QIAGEN Business Overview

7.7.3 QIAGEN Cancer Diagnostics Service Introduction

7.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2021-2026)

7.7.5 QIAGEN Recent Development

7.8 Siemens Healthcare GmbH

7.8.1 Siemens Healthcare GmbH Company Details

7.8.2 Siemens Healthcare GmbH Business Overview

7.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction

7.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2021-2026)

7.8.5 Siemens Healthcare GmbH Recent Development

7.9 Thermo Fisher Scientific, Inc.

7.9.1 Thermo Fisher Scientific, Inc. Company Details

7.9.2 Thermo Fisher Scientific, Inc. Business Overview

7.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction

7.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2021-2026)

7.9.5 Thermo Fisher Scientific, Inc. Recent Development

7.10 Applied DNA Sciences

7.10.1 Applied DNA Sciences Company Details

7.10.2 Applied DNA Sciences Business Overview

7.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction

7.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2021-2026)

7.10.5 Applied DNA Sciences Recent Development

7.11 TherapySelect

7.11.1 TherapySelect Company Details

7.11.2 TherapySelect Business Overview

7.11.3 TherapySelect Cancer Diagnostics Service Introduction

7.11.4 TherapySelect Revenue in Cancer Diagnostics Service Business (2021-2026)

7.11.5 TherapySelect Recent Development

7.12 Caris Life Sciences

7.12.1 Caris Life Sciences Company Details

7.12.2 Caris Life Sciences Business Overview

7.12.3 Caris Life Sciences Cancer Diagnostics Service Introduction

7.12.4 Caris Life Sciences Revenue in Cancer Diagnostics Service Business (2021-2026)

7.12.5 Caris Life Sciences Recent Development

7.13 Foresight Diagnostics

7.13.1 Foresight Diagnostics Company Details

7.13.2 Foresight Diagnostics Business Overview

7.13.3 Foresight Diagnostics Cancer Diagnostics Service Introduction

7.13.4 Foresight Diagnostics Revenue in Cancer Diagnostics Service Business (2021-2026)

7.13.5 Foresight Diagnostics Recent Development

7.14 Smartpraxis

7.14.1 Smartpraxis Company Details

7.14.2 Smartpraxis Business Overview

7.14.3 Smartpraxis Cancer Diagnostics Service Introduction

7.14.4 Smartpraxis Revenue in Cancer Diagnostics Service Business (2021-2026)

7.14.5 Smartpraxis Recent Development

7.15 Amadix

7.15.1 Amadix Company Details

7.15.2 Amadix Business Overview

7.15.3 Amadix Cancer Diagnostics Service Introduction

7.15.4 Amadix Revenue in Cancer Diagnostics Service Business (2021-2026)

7.15.5 Amadix Recent Development

7.16 Check4Cancer

7.16.1 Check4Cancer Company Details

7.16.2 Check4Cancer Business Overview

7.16.3 Check4Cancer Cancer Diagnostics Service Introduction

7.16.4 Check4Cancer Revenue in Cancer Diagnostics Service Business (2021-2026)

7.16.5 Check4Cancer Recent Development

7.17 Hologic

7.17.1 Hologic Company Details

7.17.2 Hologic Business Overview

7.17.3 Hologic Cancer Diagnostics Service Introduction

7.17.4 Hologic Revenue in Cancer Diagnostics Service Business (2021-2026)

7.17.5 Hologic Recent Development

7.18 RGCC

7.18.1 RGCC Company Details

7.18.2 RGCC Business Overview

7.18.3 RGCC Cancer Diagnostics Service Introduction

7.18.4 RGCC Revenue in Cancer Diagnostics Service Business (2021-2026)

7.18.5 RGCC Recent Development

7.19 ICON

7.19.1 ICON Company Details

7.19.2 ICON Business Overview

7.19.3 ICON Cancer Diagnostics Service Introduction

7.19.4 ICON Revenue in Cancer Diagnostics Service Business (2021-2026)

7.19.5 ICON Recent Development

muLu

8 Cancer Diagnostics Service Market Dynamics

8.1 Cancer Diagnostics Service Industry Trends

8.2 Cancer Diagnostics Service Market Drivers

8.3 Cancer Diagnostics Service Market Challenges

8.4 Cancer Diagnostics Service Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Cancer Diagnostics Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Cancer Diagnostics Service Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Cancer Diagnostics Service Revenue Share by Region (2021-2026)
Table 6. Global Cancer Diagnostics Service Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Cancer Diagnostics Service Revenue Share Forecast by Region (2027-2032)
Table 8. Global Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Cancer Diagnostics Service Market Share by Revenue, by Type (2021-2026)
Table 10. Global Cancer Diagnostics Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Cancer Diagnostics Service Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Cancer Diagnostics Service Market Share by Revenue, by Application (2021-2026)
Table 15. Global Cancer Diagnostics Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Cancer Diagnostics Service Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Cancer Diagnostics Service Applications
Table 18. Global Cancer Diagnostics Service Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Cancer Diagnostics Service Market Share by Players (2021-2026)
Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2025)
Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Cancer Diagnostics Service, Headquarters and Area Served
Table 24. Global Key Players of Cancer Diagnostics Service, Product and Application
Table 25. Global Key Players of Cancer Diagnostics Service, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Cancer Diagnostics Service Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Cancer Diagnostics Service Market Share by Revenue, by Company (2021-2026)
Table 29. North America Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Cancer Diagnostics Service Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Cancer Diagnostics Service Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Cancer Diagnostics Service Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Cancer Diagnostics Service Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Cancer Diagnostics Service Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Cancer Diagnostics Service Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Cancer Diagnostics Service Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Cancer Diagnostics Service Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million)
Table 47. Illumina Company Details
Table 48. Illumina Business Overview
Table 49. Illumina Cancer Diagnostics Service Product
Table 50. Illumina Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 51. Illumina Recent Development
Table 52. BGI Genomics Co.,Ltd. Company Details
Table 53. BGI Genomics Co.,Ltd. Business Overview
Table 54. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product
Table 55. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 56. BGI Genomics Co.,Ltd. Recent Development
Table 57. Agilent Technologies Company Details
Table 58. Agilent Technologies Business Overview
Table 59. Agilent Technologies Cancer Diagnostics Service Product
Table 60. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 61. Agilent Technologies Recent Development
Table 62. Macrogen Company Details
Table 63. Macrogen Business Overview
Table 64. Macrogen Cancer Diagnostics Service Product
Table 65. Macrogen Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 66. Macrogen Recent Development
Table 67. UCSF Health Company Details
Table 68. UCSF Health Business Overview
Table 69. UCSF Health Cancer Diagnostics Service Product
Table 70. UCSF Health Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 71. UCSF Health Recent Development
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott Cancer Diagnostics Service Product
Table 75. Abbott Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. QIAGEN Company Details
Table 78. QIAGEN Business Overview
Table 79. QIAGEN Cancer Diagnostics Service Product
Table 80. QIAGEN Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 81. QIAGEN Recent Development
Table 82. Siemens Healthcare GmbH Company Details
Table 83. Siemens Healthcare GmbH Business Overview
Table 84. Siemens Healthcare GmbH Cancer Diagnostics Service Product
Table 85. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 86. Siemens Healthcare GmbH Recent Development
Table 87. Thermo Fisher Scientific, Inc. Company Details
Table 88. Thermo Fisher Scientific, Inc. Business Overview
Table 89. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product
Table 90. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 91. Thermo Fisher Scientific, Inc. Recent Development
Table 92. Applied DNA Sciences Company Details
Table 93. Applied DNA Sciences Business Overview
Table 94. Applied DNA Sciences Cancer Diagnostics Service Product
Table 95. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 96. Applied DNA Sciences Recent Development
Table 97. TherapySelect Company Details
Table 98. TherapySelect Business Overview
Table 99. TherapySelect Cancer Diagnostics Service Product
Table 100. TherapySelect Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 101. TherapySelect Recent Development
Table 102. Caris Life Sciences Company Details
Table 103. Caris Life Sciences Business Overview
Table 104. Caris Life Sciences Cancer Diagnostics Service Product
Table 105. Caris Life Sciences Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 106. Caris Life Sciences Recent Development
Table 107. Foresight Diagnostics Company Details
Table 108. Foresight Diagnostics Business Overview
Table 109. Foresight Diagnostics Cancer Diagnostics Service Product
Table 110. Foresight Diagnostics Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 111. Foresight Diagnostics Recent Development
Table 112. Smartpraxis Company Details
Table 113. Smartpraxis Business Overview
Table 114. Smartpraxis Cancer Diagnostics Service Product
Table 115. Smartpraxis Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 116. Smartpraxis Recent Development
Table 117. Amadix Company Details
Table 118. Amadix Business Overview
Table 119. Amadix Cancer Diagnostics Service Product
Table 120. Amadix Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 121. Amadix Recent Development
Table 122. Check4Cancer Company Details
Table 123. Check4Cancer Business Overview
Table 124. Check4Cancer Cancer Diagnostics Service Product
Table 125. Check4Cancer Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 126. Check4Cancer Recent Development
Table 127. Hologic Company Details
Table 128. Hologic Business Overview
Table 129. Hologic Cancer Diagnostics Service Product
Table 130. Hologic Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 131. Hologic Recent Development
Table 132. RGCC Company Details
Table 133. RGCC Business Overview
Table 134. RGCC Cancer Diagnostics Service Product
Table 135. RGCC Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 136. RGCC Recent Development
Table 137. ICON Company Details
Table 138. ICON Business Overview
Table 139. ICON Cancer Diagnostics Service Product
Table 140. ICON Revenue in Cancer Diagnostics Service Business (2021-2026) & (US$ Million)
Table 141. ICON Recent Development
Table 142. Cancer Diagnostics Service Market Trends
Table 143. Cancer Diagnostics Service Market Drivers
Table 144. Cancer Diagnostics Service Market Challenges
Table 145. Cancer Diagnostics Service Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Cancer Diagnostics Service Product Picture
Figure 2. Global Cancer Diagnostics Service Market Share by Type: 2025 vs 2032
Figure 3. Breast Cancer Features
Figure 4. Blood Cancer Features
Figure 5. Lung Cancer Features
Figure 6. Colorectal Cancer Features
Figure 7. Ovarian Cancer Features
Figure 8. Others Features
Figure 9. Global Cancer Diagnostics Service Market Share by Application: 2025 vs 2032
Figure 10. Hospitals
Figure 11. Ambulatory Surgical Centers
Figure 12. Diagnostic Laboratories
Figure 13. Others
Figure 14. Cancer Diagnostics Service Report Years Considered
Figure 15. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Cancer Diagnostics Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Cancer Diagnostics Service Market Share by Revenue, by Region: 2021 vs 2025
Figure 18. North America Cancer Diagnostics Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Europe Cancer Diagnostics Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Asia-Pacific Cancer Diagnostics Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Latin America Cancer Diagnostics Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. Middle East & Africa Cancer Diagnostics Service Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. Global Cancer Diagnostics Service Market Share by Players in 2025
Figure 24. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2025)
Figure 25. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2025
Figure 26. North America Cancer Diagnostics Service Market Share by Type (2021-2026)
Figure 27. North America Cancer Diagnostics Service Market Share by Application (2021-2026)
Figure 28. Europe Cancer Diagnostics Service Market Share by Type (2021-2026)
Figure 29. Europe Cancer Diagnostics Service Market Share by Application (2021-2026)
Figure 30. Asia-Pacific Cancer Diagnostics Service Market Share by Type (2021-2026)
Figure 31. Asia-Pacific Cancer Diagnostics Service Market Share by Application (2021-2026)
Figure 32. Latin America Cancer Diagnostics Service Market Share by Type (2021-2026)
Figure 33. Latin America Cancer Diagnostics Service Market Share by Application (2021-2026)
Figure 34. Middle East & Africa Cancer Diagnostics Service Market Share by Type (2021-2026)
Figure 35. Middle East & Africa Cancer Diagnostics Service Market Share by Application (2021-2026)
Figure 36. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 37. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 38. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 39. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 40. UCSF Health Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 41. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 42. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 43. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 44. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 45. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 46. TherapySelect Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 47. Caris Life Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 48. Foresight Diagnostics Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 49. Smartpraxis Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 50. Amadix Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 51. Check4Cancer Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 52. Hologic Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 53. RGCC Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 54. ICON Revenue Growth Rate in Cancer Diagnostics Service Business (2021-2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cancer Diagnostics Service market?zhanKai
The top companies in the global Cancer Diagnostics Service market are Illumina、BGI Genomics Co.,Ltd.、Agilent Technologies.
Which region is expected to have the highest market share?shouQi
What was the global market size of Cancer Diagnostics Service in 2026?shouQi
What is the annual compound growth rate of the global Cancer Diagnostics Service market size from 2026 to 2032?shouQi
What was the global market size of Cancer Diagnostics Service in 2032?shouQi
den_biaoTiZhungShi

Related Reports

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-09

Pages: 105 Pages

Report ld: 6064703

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now